These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 23043034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M, Mullen M.
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ, Hagler DJ, Taggart NW.
    Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
    [Abstract] [Full Text] [Related]

  • 11. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
    Ponnuthurai FA, van Gaal WJ, Burchell A, Mitchell A, Wilson N, Ormerod O.
    Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
    [Abstract] [Full Text] [Related]

  • 12. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
    Becker M, Frings D, Schröder J, Ocklenburg C, Mühler E, Hoffmann R, Franke A, Lepper W.
    J Interv Cardiol; 2009 Dec; 22(6):503-10. PubMed ID: 19821880
    [Abstract] [Full Text] [Related]

  • 13. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM, Wahl A, Praz F, de Marchi SF, Mattle HP, Cook S, Windecker S, Meier B.
    Catheter Cardiovasc Interv; 2011 Apr 01; 77(5):709-14. PubMed ID: 20931665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel system for transcatheter closure of patent foramen ovale: clinical and echocardiographic outcome comparison with other contemporary devices.
    Darsaklis K, Freixa X, Asgar A, Ibrahim R, Basmadjian A, DeGuise P, Garceau P.
    Can J Cardiol; 2014 Jun 01; 30(6):639-46. PubMed ID: 24882535
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow-up.
    Greutmann M, Greutmann-Yantiri M, Kretschmar O, Senn O, Roffi M, Jenni R, Luescher TF, Eberli FR.
    Congenit Heart Dis; 2009 Jun 01; 4(4):252-7. PubMed ID: 19664027
    [Abstract] [Full Text] [Related]

  • 19. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
    Sorensen SG, Smout R, Spruance SL.
    J Interv Cardiol; 2011 Aug 01; 24(4):366-72. PubMed ID: 21492220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.